StockData
Sera Prognostics, Inc. logo

Sera Prognostics, Inc. (SERA) stock

SERANasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 5/30
$2.00+0.06 (+3.09%)

Close on Nov 17, 2026Market cap $78.90MP/E –Yield –

Sera Prognostics operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Sera Prognostics's operating cash flow for the twelve months ending Jun 30, 2026 was -$27.68M. For fiscal 2025 it was -$25.62M. The highest annual figure on record is -$14.19M in fiscal 2024.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$25.62M–
FY2024Dec 31, 2024-$14.19M–
FY2023Dec 31, 2023-$27.19M–
FY2022Dec 31, 2022-$34.61M–
FY2021Dec 31, 2021-$31.64M–
FY2020Dec 31, 2020-$16.87M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$6.31M–
Q1 FY2026Mar 31, 2026-$8.77M–
Q4 FY2025Dec 31, 2025-$6.12M–
Q3 FY2025Sep 30, 2025-$6.48M–
Q2 FY2025Jun 30, 2025-$5.47M–
Q1 FY2025Mar 31, 2025-$7.55M-251.2%
Q4 FY2024Dec 31, 2024-$6.26M–
Q3 FY2024Sep 30, 2024-$7.00M–
Q2 FY2024Jun 30, 2024-$5.93M–
Q1 FY2024Mar 31, 2024$4.99M–
Q4 FY2023Dec 31, 2023-$6.77M–
Q3 FY2023Sep 30, 2023-$7.59M–
Q2 FY2023Jun 30, 2023-$7.95M–
Q1 FY2023Mar 31, 2023-$4.88M–
Q4 FY2022Dec 31, 2022-$7.24M–
Q3 FY2022Sep 30, 2022-$8.78M–
Q2 FY2022Jun 30, 2022-$9.04M–
Q1 FY2022Mar 31, 2022-$9.56M–
Q4 FY2021Dec 31, 2021-$9.15M–
Q3 FY2021Sep 30, 2021-$9.30M–
Q2 FY2021Jun 30, 2021-$6.24M–
Q1 FY2021Mar 31, 2021-$6.95M–
Q4 FY2020Dec 31, 2020-$4.19M–
Q3 FY2020Sep 30, 2020-$3.92M–

More Sera Prognostics figures

See a number that looks wrong?